ClinicalTrials.gg
Status unknownNCT04946175Updated Jun 30, 2021

National Survey Among Egyptian Pain Practitioners

An observational study in Survey, sponsored by South Valley University. Status unknown at 2 sites in Egypt. Per ClinicalTrials.gov, last updated 2021-06-30.

Sponsored by South Valley University · Observational

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
500
Sex
All
01

Study summary

Coronavirus pandemic health restrictions has deleteriously affected the rates of all interventional procedures even for emergency cases. This study tried to evaluate the impact of the outbreak of SARS-CoV-19 infection on rates of interventional pain therapy (IPT).

Read the detailed description

Background: Coronavirus pandemic health restrictions has deleteriously affected the rates of all interventional procedures even for emergency cases. This study tried to evaluate the impact of the outbreak of SARS-CoV-19 infection on rates of interventional pain therapy (IPT).

Methods: Setting: Multicenter Study. Design: Prospective observational study, approved by the Local Ethical Committee (RC:2-1-21). Materials: Two 20-item questionnaires with five choices for probable answer using a Likert-5 point scale were constructed as self-assessment questionnaire. The questionnaires were uploaded to the Google drive, and the links and identification codes were sent using the WhatsApp to 500 IPT providers. The feedback answers were scored and statistically analyzed. Statistical analyses will be performed using IBM® SPSS® Statistics (Version 22, 2015; Armonk, USA) for Windows statistical package. P value \<0.05 was considered statistically significant.

02

Conditions studied

  • Survey
03

In context

Lead sponsor

South Valley University is the lead sponsor of 153 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

registered pain practitioners in Egypt.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

registered pain practitioners in Egypt.

-

Exclusion criteria

Exclusion Criteria:

Non registered pain practitioners

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. number of interventional pain procedures

    questionnaire

    Time frame: June 1st 2020 till June 1st 2021

Secondary outcomes

  1. wearing protective clothing

    during covid 19 pandemic

    Time frame: june 1st 2020 to june 1st 2021

07

Study locations

2 sites
  • South Valley University Hospitals
    Qina, Qena Governorate 85203, Egypt
  • South Valley University
    Qina, 83523, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2021; primary completion for Sep 2021, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2021
First posted
Jun 30, 2021
StartEst.
Jun 25, 2021
Primary completionEst.
Sep 1, 2021
CompletionEst.
Sep 1, 2021
Last update
Jun 30, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04946175
Responsible party
Ossama Hamdy Salman (Associate Professor, South Valley University) — Principal investigator
First posted
Jun 30, 2021
Start date
Jun 25, 2021 (estimated)
Primary completion
Sep 1, 2021 (estimated)
Completion
Sep 1, 2021 (estimated)
Last update
Jun 30, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion